Fritextsökning
Innehållstyper
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Pfizer höjer budet på Astrazeneca
Pfizer beskriver det nya budet, på 607 kronor aktien, som det "sista", men räknar inte med att Astrazenecas styrelse kommer att acceptera erbjudandet.
-
New CEO to Promedvi
Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.
-
Budar på Sobi
Läkemedelsbolaget mottog nyligen ett bud från en ospecificerad budgivare.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Forskare får hjälp att fatta beslut
En ny mjukvara ska samla in och tolka resultat från kliniska prövningar.
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Ozzy Osbournes DNA under lupp
Ett amerikanskt företag ska granska Ozzy Osbournes DNA för att ta reda på hur han kan ha överlevt 40 år av drog- och alkoholmissbruk.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Mathematician new dean at DTU
On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.
-
Ryssland satsar på klinisk forskning
Ryska Quintiles och statlig kapitalfond samarbetar i ny hälsoplan som ska sätta landets kliniska forskning på världskartan.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Almost 150 will leave Coloplast
The Danish medtech company Coloplast negotiates headcount reductions, with a total number of almost 150 employees.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
High hopes for future partnering - the solution for struggling fairs
Business fairs are struggling but the concept of partnering is hotter than ever. By using social media, participants can prepare themselves for the perfect meeting.
-
Snedfördelning av Europeiska forskningsrådets anslag
Risk för "brain drain" inom Europa enligt polsk professor.
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Swedish multi competent machine soon launched
The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.
-
Absorber säljer till USA
Två ledande amerikanska transplantationskliniker köper bolagets antikroppstest.
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.